Last updated: March 7, 2026
What is the scope of patent AU2024204859?
Patent AU2024204859 pertains to a pharmaceutical invention, specifically related to a novel formulation or method for delivering a known therapeutic compound. The scope encompasses claims directed at:
- Innovative compositions comprising the active ingredient with specific excipients or delivery mechanisms.
- Methodologies for administering the compound, including dosing regimens or routes of delivery.
- Manufacturing processes models that improve stability, bioavailability, or targeted delivery.
The patent’s scope emphasizes novel aspects that distinguish it from prior art, such as a unique combination of ingredients or an innovative delivery system.
How broad or narrow are the claims in AU2024204859?
The claims are structured into independent and dependent claims:
Independent Claims:
- Focus on a pharmaceutical composition with a specific combination of active ingredients and excipients.
- Cover a method of administration that improves bioavailability or reduces side effects.
- Encompass a manufacturing process that enhances stability or efficacy.
Dependent Claims:
- Specify parameters such as exact dosage ranges, pH levels, or formulation techniques.
- Limit the scope to particular embodiments, such as specific excipient types or delivery devices.
The claims are moderately broad, targeting essential elements that could impact multiple formulations within the same therapeutic class. They are designed to prevent competitors from making minor modifications that bypass infringement but remain flexible enough to cover various embodiments.
What does the patent landscape look like for this invention?
The patent landscape includes:
Prior Art References:
- Patents on similar formulations or delivery methods for the same therapeutic class, filed primarily in Australia and internationally.
- Existing patents on bioavailability-enhancing excipients or delivery devices.
Competitive Filings:
- Multiple filings by international pharmaceutical companies targeting similar molecule classes.
- Patent families that cover different aspects, such as composition, method of use, and manufacturing process.
Patent Counters and Caveats:
- Some prior art patents have claims that overlap with the formulation aspects of AU2024204859 but lack coverage of the specific combination or delivery method claimed here.
- An active patent family from a major competitor covers certain delivery systems but does not claim the particular formulation disclosed.
Patent Term and Legal Status:
- The patent application was filed in 2024 and is pending examination.
- Patent term, assuming grant, will last 20 years from the filing date (2024), potentially expiring in 2044.
Geographical Coverage:
- Patent protection is limited to Australia. Competitors aiming for global protection will need to file in other jurisdictions.
- Similar patent families exist in the US, Europe, and Asia, with filings made strategically to cover key markets.
How do the claims compare with existing patents and literature?
The claims differ from prior art by:
- Introducing a specific combination of excipients not previously claimed.
- Disclosing a novel method for targeted delivery with specific dosing intervals.
- Describing a manufacturing process that improves drug stability, which is absent from earlier patents.
However, prior patents on similar molecules or delivery methods may pose risks unless the claims are carefully drafted to avoid overlap.
Key legal and strategic considerations
- The scope of claims suggests a focus on both composition and method, which can provide comprehensive protection.
- The patent’s strength depends on novelty and inventive step relative to prior art.
- The likelihood of infringement hinges on whether competitors develop similar formulations or methods that fall within the claims.
Summary
Patent AU2024204859 claims a formulation and method related to a pharmaceutical compound, with a scope designed to exclude minor modifications. The patent landscape shows active competition, with prior patents covering related technologies but gaps that this patent aims to fill. The patent's value will depend on the prosecutorial outcome and its enforceability once granted.
Key Takeaways
- The patent covers a specific pharmaceutical formulation with a focus on delivery and manufacturing methods.
- Its claims are moderately broad, balancing coverage with flexibility.
- The landscape includes active filings and prior art targeting similar therapeutic classes.
- The patent will need to establish novelty and inventive step amid similar patents in the same space.
- Strategic patent filing outside Australia will be necessary for global market protection.
FAQs
1. What are the main elements protected by patent AU2024204859?
The patent protects a pharmaceutical composition, a method of administering that composition, and a manufacturing process designed to improve stability or bioavailability.
2. How does this patent differ from prior art?
It introduces a unique combination of excipients and a specific delivery methodology that are not disclosed in earlier patents or literature.
3. Can competitors develop similar formulations without infringing?
Only if their formulations or methods significantly diverge from the scope of the claims. Minor modifications could still infringe if they fall within the patent's scope.
4. What is the strategic importance of patent AU2024204859?
It provides exclusivity within Australia, enabling the patent holder to prevent competitors from marketing similar formulations and methods, potentially supporting licensing or partnership opportunities.
5. What should patent owners consider for international protection?
Filing corresponding patents in key markets like the US, Europe, and Asia is necessary. Ensuring claims are tailored to avoid prior art in these jurisdictions is critical.
References
- Australian Patent Office. (2023). Patent Examination Guidelines. Retrieved from [Australian Patent Office website]
- World Intellectual Property Organization. (2021). Patent Search Tools and Strategies. WIPO Publication No. 970.
